Concentra Group (NYSE:CON) stock is set to start trading on Thursday after the occupational health services company announced the pricing of shares in its initial public offering (IPO).
Let’s dive into everything investors need to know about Concentra Group starting to trade today below!
CON Stock: Details on Concentra Group
- Shares of Concentra Group stock will start trading later today on the New York Stock Exchange under the CON ticker.
- The Concentra Group IPO includes 22.5 million shares of CON stock priced at $23.50 each.
- Underwriters also have a 30-day option to acquire another 3,375,000 shares of CON stock at the IPO price.
- Investors will note that Select Medical (NYSE:SEM) is the parent company of Concentra Group.
- After the IPO, Select Medical will own 104,093,503 shares of CON stock.
- That represents an 82.23% stake in the company or an 80.09% stake if underwriters exercise their options.
- The IPO for CON shares will end on Friday.
Traders will want to keep a close eye on CON stock when trading starts today. The company’s performance on its first day of trading will show if investors believe that $23.50 per share is a good price for the stock.
There are even more stock market stories traders are going to want to learn about below!
We have all of the hottest stock market news investors need to know about on Thursday! Among that is what has shares of Southwest Airlines (NYSE:LUV), Super Micro Computer (NASDAQ:SMCI) and Viking Therapeutics (NASDAQ:VKTX) stock on the move this morning. You can dive into all of that info at the following links!
More Thursday Stock Market News
- Goodbye Open Seating! Southwest Airlines Announces Major Policy Shift.
- Dear SMCI Stock Fans, Mark Your Calendars for Aug. 6
- Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
